Let’s Reach Your Development Milestones Together

William Rash

Senior Director, Business Development

Mr. Rash serves as Senior Director of Business Development at ProtaGene (previously BioAnalytix). He is a commercial leader and serial entrepreneur with 35 years of experience focused on CMC/development of complex biologics. Mr. Rash began his career in the lab as a protein scientist and progressed to global leadership roles in corporate and business development. His expertise ranges from characterization and QC technologies application for pre-clinical and clinical development of recombinant protein biologics to facilities and laboratory operational management to global sales and marketing. With an established career in complex biologics, Mr. Rash is adept at identifying opportunities and working with partners to tap into exciting areas in the biopharma industry.

Before joining ProtaGene, Mr. Rash held roles of increasing technical, corporate, operational, and business development responsibility at Blue Stream Laboratories, Essenix Pharmaceuticals, Charles River Laboratories, Wyeth Pharmaceuticals, Ascent Biotechnology Recruiters, Hospital at the University of Pennsylvania, and Tektagen.

Mr. Rash holds a B.S. in Microbiology from West Chester.

Analytical Solutions from Research to Market

Group Created with Sketch.
Research
Preclinical
Group 2 Created with Sketch.

Discovery – Pre-clinical

Biologic Candidate Evaluation, Optimization and Selection into IND

Group 3 Created with Sketch.
Phase I
Phase II
Phase III
Group 4 Created with Sketch.

Phase I – Phase III

Release, Clinical Data and Characterization Packages for Accelerating Phase I-III Programs through BLA

Group Created with Sketch.
Registration
Market
Group 2 Created with Sketch.

Registration – Market

Commercial-Stage Comparability Testing by Qualified Advanced Methods

Biologic Therapeutics
Platform Expertise

  • bullet Created with Sketch.

    mAbs

  • bullet Created with Sketch.

    Bispecifics/Multispecifics

  • bullet Created with Sketch.

    Recombinant Proteins—Including Complex, Highly Glycosylated Proteins

  • bullet Created with Sketch.

    Multi-subunit Complexes—Protein, Nucleotide, Ligand

  • bullet Created with Sketch.

    Fusion Proteins

  • bullet Created with Sketch.

    Enzyme Replacement Therapies

  • bullet Created with Sketch.

    ADCs and Protein Conjugates

  • bullet Created with Sketch.

    PEGylated Proteins

  • bullet Created with Sketch.

    Biosimilars

  • bullet Created with Sketch.

    Vaccines, Including Subunit/Recombinant

Cell and Gene Therapeutic Platform Expertise

  • bullet Created with Sketch.

    Capsid-based Vectors

  • bullet Created with Sketch.

    Complex, Envelope Vectors

  • bullet Created with Sketch.

    Non-viral Vectors

  • bullet Created with Sketch.

    Genetic Engineering